FDA Commissioner Nominee Avoids Addressing Trump's Medical Claims in Hearing
Heidi Overton, the nominee for FDA commissioner under the Trump administration, avoided answering questions regarding her stance on President Trump’s frequently misleading or false medical claims during a Senate hearing. The hearing took place as part of the confirmation process for her nomination to lead one of the country's most influential public health agencies. Overton, who is an experienced physician and currently serves in a deputy role at the FDA, was pressed by senators about how she would handle situations where Trump’s statements on medical issues conflicted with scientific consensus. However, Overton did not provide direct responses to these inquiries, raising concerns among some lawmakers regarding her willingness or ability to challenge misinformation from high-ranking officials. The hearing highlighted broader tensions around the role of public health agencies in an administration known for its controversial rhetoric and skepticism toward expert guidance.
Topics: FDA government regulation public health